制药巨头Gland Pharma可能被以214亿转卖。该公司由PVN Raju创立,是复星医药控股子公司,业务覆盖全球60国,近年还布局了复杂注射制剂及生物药CDMO业务。尽管复星医药逐渐减持Gland Pharma股份,但依然保持控股权。
Source Link制药巨头Gland Pharma可能被以214亿转卖。该公司由PVN Raju创立,是复星医药控股子公司,业务覆盖全球60国,近年还布局了复杂注射制剂及生物药CDMO业务。尽管复星医药逐渐减持Gland Pharma股份,但依然保持控股权。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.